SNo Title of the Paper Status of Publication Download
1 Isolation and characterization of the new SARS-CoV-2 variant in travellers from the United Kingdom to India: VUI-202012/01 of the B.1.1.7 lineage Published in Journal of Travel Medicine
Oxford University Press
2 Inactivated COVID-19 vaccine BBV152/COVAXIN effectively neutralizes recently emerged B.1.1.7 variant of SARS-CoV-2 Published in Journal of Travel Medicine
Oxford University Press
3 Imported SARS-CoV-2 V501Y.V2 variant (B.1.351) detected in travellers from South Africa and Tanzania to India Published in Travel Medicine & Infectious Diseases
Elsevier, Netherlands
4 An epidemiological analysis of SARS-CoV-2 Genomic Sequences from Different Regions of India Published in Viruses
MDPI, Switzerland
5 Neutralization of B.1.1.28 P2 variant with sera of natural SARS-CoV-2 infection and recipients of inactivated COVID- 19 vaccine Covaxin Pre-proof published in Journal of Travel Medicine
Oxford University Press
6 Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees Pre-proof published in Clinical Infectious Diseases
Oxford University Press
7 SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India Published in Microorganisms
MDPI, Switzerland
8 Comparison of SARS-CoV-2 VOC 202012/01 (UK variant) and D614G variant transmission by different routes in Syrian hamsters Published in Vector Borne & Zoonotic Diseases
Mary Ann Liebert, Inc. Publishers, USA
9 Neutralization potential of Covishield vaccinated individuals sera against B.1.617.1 Accepted in Clinical Infectious Diseases
Oxford University Press
10 Detection of SARS-CoV-2 variants in India from UK returnees Accepted in Infection
Springer, Germany
11 SARS CoV-2 variant B.1.617.1 is highly pathogenic in hamsters than B.1 variant Under review in Clinical Infectious Diseases
Released on BioRxiv
12 Comparison of the pathogenicity and virus shedding of SARS CoV-2 VOC 202012/01 and D614G variant in hamster model Under review in Scientific reports
Released on BioRxiv
13 Isolation and characterization of SARS-CoV-2 VOC, 20H/501Y.V2, from UAE travellers Under review in Travel Medicine & Infectious Diseases
Released on BioRxiv
14 Possible role of accessory proteins in the viral replication for the 20I/501Y.V1 (B.1.1.7) SARS-CoV-2 variant Under review in Scientific Reports
Released on BioRxiv
15 Isolation of SARS-CoV-2 B.1.1.28.2 P2 variant and pathogenicity comparison with D614G variant in hamster model Under review in Journal of Infection and Public Health
Released on BioRxiv
16 Detection of SARS CoV-2 VUI-202102/03 variant (B.1.525) from India. Under review in Indian Journal of Medical Research
17 Neutralization against B.1.351 and B.1.617.2 with sera of COVID-19 recovered cases and vaccinees of BBV152 BioRxiv preprint
18 Neutralization of Delta variant with sera of Covishield vaccinees and COVID-19 recovered vaccinated individuals BioRxiv preprint
19 Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/COVAXIN Published in Journal of Travel Medicine
Oxford University Press
20 Clinical characterization and Genomic analysis of COVID-19 breakthrough infections during second wave in different states of India medRxiv preprint
21 Development of double antibody sandwich ELISA as potential diagnostic tool for rapid detection of Crimean‑Congo hemorrhagic fever virus Published in Scientific Reports
Nature Portfolio

© Copyright 2020 by ICMR. All Rights Reserved. Designed by BMI division ICMR.   |   Website Policies